Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
627 results:

  • 1. The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in colorectal cancer.
    Sun J; Zhao Z; Lu J; An W; Zhang Y; Li W; Yang L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612546
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Synthesis and biological evaluation of echinomycin analogues as potential colon cancer agent.
    Kojima K; Konishi H; Momosaki K; Komatani Y; Katsuyama A; Nakagawa K; Kanamitsu K; Yakushiji F; Fujiya M; Ichikawa S
    Sci Rep; 2024 Apr; 14(1):7628. PubMed ID: 38561454
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HIF-1α Mediates Immunosuppression and Chemoresistance in colorectal cancer by Inhibiting CXCL9, -10 and -11.
    Su Y; Liu J; Tian Y; Dong H; Shi M; Zhang J; Li W; Huang Q; Xiang N; Wang C; Liu J; He L; Hu L; Haberman AM; Liu H; Yang X
    Biomed Pharmacother; 2024 Apr; 173():116427. PubMed ID: 38484558
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MITF regulates the subcellular location of HIF1α through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells.
    Zheng M; Tian S; Zhou X; Yan M; Zhou M; Yu Y; Zhang Y; Wang X; Li N; Ren L; Zhang S
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456491
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
    Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
    Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
    Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
    J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Post-surgery financial toxicity and its influencing factors in colorectal cancer care: A cross-sectional study.
    Shao M; Yao L; Zhang M; Zhou H; Ding Y; Bai L; Ma B; Li T; Guo S; Chen C; Wang T
    Eur J Oncol Nurs; 2024 Feb; 68():102518. PubMed ID: 38309254
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in colorectal cancer.
    Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS
    Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Extracellular vesicles from
    Shi Y; Zhang C; Cao W; Li L; Liu K; Zhu H; Balcha F; Fang Y
    Future Microbiol; 2024 Feb; 19():227-239. PubMed ID: 38270125
    [No Abstract]    [Full Text] [Related]  

  • 11. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
    Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
    Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The emerging role of hypoxia and environmental factors in inflammatory bowel disease.
    Villareal LB; Xue X
    Toxicol Sci; 2024 Mar; 198(2):169-184. PubMed ID: 38200624
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression.
    Montecchi T; Nannini G; De Tommaso D; Cassioli C; Coppola F; Ringressi MN; Carraro F; Naldini A; Taddei A; Marotta G; Amedei A; Baldari CT; Ulivieri C
    Cancer Immunol Immunother; 2024 Jan; 73(1):2. PubMed ID: 38175205
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long non-coding RNA NBR2 suppresses the progression of colorectal cancer by downregulating miR-19a to regulate M2 macrophage polarization.
    Yang X; Luo Y; Li M; Jin Z; Chen G; Gan C
    Chin J Physiol; 2023; 66(6):546-557. PubMed ID: 38149567
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HIF-1α/METTL1/m
    Mi S; Cai S; Xue M; Wu W
    Biochem Biophys Res Commun; 2024 Jan; 693():149385. PubMed ID: 38118310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation.
    Hwang SJ; Cho SH; Bang HJ; Hong JH; Kim KH; Lee HJ
    Biochem Pharmacol; 2024 Feb; 220():115972. PubMed ID: 38072164
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression.
    Jiang J; Wang W; Zhu L; Shi B; Chen Y; Xia Y; Feng W; Yao W; Lu A; Zhang H
    Front Immunol; 2023; 14():1260638. PubMed ID: 38022589
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chanling Gao suppresses colorectal cancer via PI3K/Akt/mTOR pathway modulation and enhances quality of survival.
    Chen G; Tian TT; Wang FQ; Pan CS; Sun K; Wang XY; Yang B; Yang Z; Tang DX; Han JY
    Environ Toxicol; 2024 Mar; 39(3):1107-1118. PubMed ID: 37823609
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis.
    Kim KH; Park YL; Park SY; Joo YE
    Pathol Res Pract; 2023 Nov; 251():154875. PubMed ID: 37820439
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with hif1a.
    Mu M; Zhang Q; Li J; Zhao C; Li X; Chen Z; Sun X; Yu J
    Cell Death Differ; 2023 Nov; 30(11):2393-2407. PubMed ID: 37816999
    [TBL] [Abstract] [Full Text] [Related]  


    of 32.